We investigated the heterogeneity of four cell types of BLCA, evaluated the TF activity of different immune cells in BLCA, identified two distinct subtypes of CAFs, identified different states of normal-to-malignant cell transformation in epithelial cells, and identified five genes to construct a prognostic model. This evidence concerns the gene TF and bladder transitional cell carcinoma.